Sucampo Pharma Inc (SCMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 154,897 | 157,021 | 163,502 | 93,432 | 71,556 |
| Marketable Securities | N/A | N/A | N/A | 38,022 | 37,153 |
| Receivables | 36,911 | 32,575 | 45,551 | 26,010 | 24,338 |
| Inventories | 21,570 | 24,437 | 33,121 | 296 | 308 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 259 |
| Other current assets | 0 | 0 | 295 | 0 | 295 |
| TOTAL | $237,702 | $228,130 | $251,360 | $161,446 | $136,713 |
| Non-Current Assets | |||||
| PPE Net | 6,340 | 6,944 | 6,393 | 2,296 | 526 |
| Investments And Advances | 0 | 0 | 0 | 5,124 | 16,655 |
| Intangibles | 211,186 | 199,386 | 191,252 | 136 | 141 |
| Other Non-Current Assets | 14,516 | 13,750 | 8,176 | 4,770 | 6,222 |
| TOTAL | $232,042 | $220,080 | $205,821 | $12,326 | $23,544 |
| Total Assets | $469,744 | $448,210 | $457,181 | $173,772 | $160,257 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,166 | 5,135 | 11,213 | 4,936 | 3,910 |
| Accrued Expenses | 13,298 | 13,689 | 10,886 | 10,151 | 8,660 |
| Other current liabilities | 8,218 | 12,294 | 19,762 | 8,133 | 7,853 |
| TOTAL | $55,635 | $62,425 | $88,127 | $33,474 | $32,841 |
| Non-Current Liabilities | |||||
| Long Term Debt | 202,410 | 207,862 | 213,277 | 13,330 | 13,330 |
| Deferred Revenues | N/A | N/A | 676 | 1,152 | 1,728 |
| Other Non-Current Liabilities | 18,428 | 16,951 | 15,743 | 4,384 | 2,125 |
| TOTAL | $290,345 | $284,942 | $282,605 | $22,510 | $20,692 |
| Total Liabilities | $345,980 | $347,367 | $370,732 | $55,984 | $53,533 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,821 | 45,789 | 45,539 | 45,317 | 45,244 |
| Common Shares | 458 | 456 | 455 | 453 | 451 |
| Retained earnings | 14,750 | 15,582 | 19,639 | 9,488 | 2,252 |
| Other shareholders' equity | 49,423 | 28,690 | 13,143 | 14,098 | 13,783 |
| TOTAL | $123,764 | $100,843 | $86,449 | $117,788 | $106,724 |
| Total Liabilities And Equity | $469,744 | $448,210 | $457,181 | $173,772 | $160,257 |